BROOKS LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Brooks Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.66₹ 1.85
As on Oct 31, 2025, 4:01 PM IST
Brooks Laboratories Price Performance
Today's LowToday's High
₹109.45₹115.00
₹113.00
52 Weeks' Low52 Weeks' High
₹97.80₹202.80
₹113.00
Open Price
₹114.95
Prev. Close
₹111.15
Volume
1,745
Over the last 5 years, the share price of Brooks Laboratories has gained 17.97% CAGR. Over the past year, the corresponding return has been -19.08%.
Brooks Laboratories’s current P/E of -818.84x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Brooks Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Brooks Laboratories | -0.66 | -14.10 | -27.07 | -16.17 | -19.08 | 2.81 | 17.97 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Brooks Laboratories has declined 19.08% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Brooks Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Brooks Laboratories Financials
Brooks Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 115.47 | 111.4 |
| 10 | 119.52 | 115.34 |
| 20 | 125.12 | 121.84 |
| 50 | 138.2 | 132.28 |
| 100 | 141.84 | 136.96 |
| 200 | 139.14 | 137.19 |
Brooks Laboratories Share Holding Pattern
In the latest quarter, Brooks Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 10.38%, FII holding rose to 0.01%, and public shareholding unchanged at 37.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Brooks Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 17, 2025, 2:25 AM IST | Brooks Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
| Oct 09, 2025, 10:43 PM IST | Brooks Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 27, 2025, 10:35 PM IST | Brooks Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 27, 2025, 4:52 AM IST | Brooks Laboratories - ''Merger Of Brooks Steriscience Limited (BSL), A Joint Venture/Associate Of The Company, Through A Comp |
| Sep 27, 2025, 4:06 AM IST | Brooks Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
About Brooks Laboratories
Brooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 82.56 Cr. and Equity Capital is Rs. 29.46 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressUnit 1: Village Kishanpura,. Solan District Himachal Pradesh 174101
- Contact
Management
- Ms. Sonia GuptaIndependent Director
- Mr. Jitendra Pratap SinghWhole Time Director
- Mr. Durga Shankar MaityWhole Time Director
- Mr. Bhushan Singh RanaWhole Time Director
- Mr. Lalit MahajanAddnl.Independent Director
- Dr. Usha SinghAddnl.Independent Director
FAQs on Brooks Laboratories Share Price
What is the share price of Brooks Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Brooks Laboratories is ₹113.00 as on Oct 31, 2025.
What kind of stock is Brooks Laboratories?
The Brooks Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Brooks Laboratories?
The market cap of Brooks Laboratories is ₹332.87 Cr as on Oct 31, 2025.
What are today's High and Low prices of Brooks Laboratories?
Today’s highest and lowest price of Brooks Laboratories are ₹115.00 and ₹109.45.
What are the 52 Week High and 52 Week Low of Brooks Laboratories?
The 52-week high/low is the highest and lowest price at which Brooks Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Brooks Laboratories is ₹202.80 and 52-week low of Brooks Laboratories is ₹97.80 as on Oct 31, 2025.
How has the Brooks Laboratories performed historically in terms of returns?
The Brooks Laboratories has shown returns of 1.66% over the past day, -14.1% for the past month, -27.07% over 3 months, -19.08% over 1 year, 2.81% across 3 years, and 17.97% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Brooks Laboratories?
P/E ratio of and PB ratio of Brooks Laboratories are -818.84 and 5.33 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse